Tillie-Louise Hackett

Tillie-Louise Hackett

Professor
Vice Chair, Research – Anesthesiology, Pharmacology & Therapeutics
Tier 1 Canada Research Chair in Asthma and COPD Lung Pathobiology & Therapeutics
Investigator, Centre for Heart Lung Innovation
St. Paul’s Hospital

Faculty Bio

BSc. (2002) in Biochemistry and Pharmacology, University of Southampton, United Kingdom. Ph.D. (2006) in Cellular and Biological Sciences, University of Southampton, United Kingdom. Post-doctoral Fellow (2006), Centre for Heart Lung Innovation, University of British Columbia. Post-doctoral Fellow(2010), University Medical Centre Groningen, the Netherlands. Dr. Hackett is an internationally recognized leader in ultra-resolution biomedical imaging modalities and human in vitro models to investigate and treat the pathobiology of asthma and chronic obstructive pulmonary disease (COPD), which daily affects the ability of over 4.5 million Canadians to breathe. Dr. Hackett’s research has been formally recognized by over 40 awards, including the Parker B. Francis Fellowship (2012), Canadian Institutes of Health Research New Investigator Award (2014), and the UBC Faculty of Medicine Distinguished Researcher Award (2018). In 2018, she was named an Inaugural American Thoracic Society Fellow (100 awarded), a mark of distinction and recognition for accomplishments and dedication to the society and field of pulmonary, critical care, and sleep medicine. In 2021, Dr Hackett was awarded at Tier I Canada Research Chair in asthma and COPD pathobiology & therapeutics. Dr. Hackett has published over 120 peer-reviewed articles and ranks in the top 0.2% of 157,339 published authors worldwide on obstructive lung diseases (Expertscape.com). Since 2014, Dr. Hackett has served as the Director of the HLI James C. Hogg Lung Tissue Biobank. Established in 1977, it is one of the largest biobanks in the world, enabling researchers from academia, health authorities, and industry to access comprehensively phenotyped lung samples from over 3,000 patients. Between 2013 – 2018,Dr. Hackett served as the Associate Director of the Centre for Heart Lung Innovation. Dr. Hackett has served as the primary supervisor for 5 MSc and 11PhD students, 6 postdoctoral fellows, 10 co-op students, 12 summer students, 3 clinical fellows, and 5 BSc Honours students, who have collectively won over 97 fellowships, travel awards, and best presentation awards. Since 2017, she has been recognized annually by the Dean of the Faculty of Sciences for Excellence in Student Teaching.

Social Media / Lab or Research Website

Website (or Lab): https://hackettlab.med.ubc.ca/


Research Interests

Biomedical Imaging; Asthma; COPD; Fibrosis; In vitro lung models

Research Theme(s)

Cardiopulmonary Sciences and anesthesiology

Publication Link(s)

ORCID: 0000-0001-7134-3287

PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=hackett+TL

Google Scholar: https://scholar.google.ca/citations?user=n_1As1AAAAAJ&hl=en


Clinical Interests

Asthma, COPD, Idiopathic pulmonary fibrosis


Services

Since 2021, Dr. Hackett has served as the Vice Chair of Research for the Department of Anesthesiology, Pharmacology & Therapeutics. Since 2014, Dr.Hackett has served as the Director of the HLI James C. Hogg Lung Tissue Biobank. Established in 1977, it is one of the largest biobanks in the world,enabling researchers from academia, health authorities, and industry to access comprehensively phenotyped lung samples from over 3,000 patients.Between 2013 – 2018, Dr. Hackett served as the Associate Director of the Centre for Heart Lung Innovation


Teaching

PCTH_V 325

PCTH_V 400

PCTH_V 548F

PATH_V 521

PCTH_V 518

MEDD 411 (COPD week lead for the Medical School Program)